- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Vornoxant, as a novel orexin receptor antagonist, mainly involves central nervous system and digestive system reactions in its side effects, requ...
Vornoxant, as a novel orexin receptor antagonist, is mainly used to treat chronic insomnia in adults. Its use requires special attention to cen...
Olmetec, as an angiotensin II receptor antagonist, is mainly used for the treatment of hypertension. Its usage needs to be adjusted according t...
Olmetec, as a long-acting antihypertensive drug, has significant therapeutic effects and good safety. However, caution should be exercised when...
Aprepitant, as a neurokinin-1 receptor antagonist, is mainly used for the prevention of chemotherapy-induced nausea and vomiting. Its side effe...
Aprepitant, as a neurokinin-1 receptor antagonist, is mainly indicated for the prevention and treatment of chemotherapy-induced nausea and vomi...
Bedaquiline, as an anti tuberculosis drug, has specific contraindications, dietary restrictions, and medication conditions that need to be stri...
As the core drug for the treatment of multidrug-resistant tuberculosis, the use and dosage of Bedaquiline should strictly follow the weight str...
Bedaquiline, as a novel anti tuberculosis drug, has a unique mechanism of action and complex drug interactions, which requires special attentio...
Bedaquiline has shown significant efficacy in the treatment of multidrug resistant tuberculosis, but it is necessary to standardize the drug wi...
